Results

1–8 of 8 results for exudative age-related macular degeneration

Accuracy of Diagnosis Codes for Patients With Concurrent Geographic Atrophy and Exudative Age-Related Macular Degeneration
Jong G Park, MD
Annual Meeting Talks
2023
Charlson Comorbidity Index As a Predictive Tool in Patients With Exudative Age-Related Macular Degeneration in Delay of Care
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2024
Conversion Rates from Nonexudative to Exudative Age-Related Macular Degeneration: An AAO IRIS® Registry Analysis
Dan A Gong, MD
Annual Meeting Talks
2022
Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Annual Meeting Talks
2020
Ten-Year Follow-Up of Patients With Exudative Age-Related Macular Degeneration Treated With Intravitreal Anti-VEGF Injections
Sophie Jane Bakri, MD
Annual Meeting Talks
2020
Intravitreal Bevacizumab vs. Bevacizumab with Dexamethasone for the Treatment of Exudative Age-Related Macular Degeneration
Reda Issa, MD
On Demand Cases, Courses, and Papers
2019
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD): Diagnosis, Treatment, and Correlation to IVFA and ICG Videoimaging
Mark H. Nelson, MD, MBA
Annual Meeting Talks
2017
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD)
Mark H. Nelson, MD, MBA
Updates from the Field
2017